Rain Oncology Inc. Financing Cash Flow
Rain Oncology Inc. reported Financing Cash Flow of $478.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-11-09
- Rain Oncology Inc. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Rain Oncology Inc. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $12.00K, a 0.00% change year-over-year.
- Rain Oncology Inc. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $466.00K, a 16.79% increase year-over-year.
- Rain Oncology Inc. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $52.61M, a 146030.56% increase year-over-year.
- Rain Oncology Inc. net cash provided by (used in) financing activities for fiscal 2022 was $53.18M, a 56.27% decline from fiscal 2021.
- Rain Oncology Inc. net cash provided by (used in) financing activities for fiscal 2021 was $121.61M, a 75.01% increase from fiscal 2020.
- Rain Oncology Inc. net cash provided by (used in) financing activities for fiscal 2020 was $69.49M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $12.00K derived: sum of 2 quarters · filed 2023-11-09 | $478.00K 10-Q · filed 2023-11-09 | $53.09M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $478.00K 10-Q · filed 2023-08-10 | $53.09M derived: sum of 3 quarters · filed 2023-08-10 | $53.25M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $466.00K 10-Q · filed 2023-05-11 | $53.07M derived: sum of 2 quarters · filed 2023-05-11 | $53.23M derived: sum of 3 quarters · filed 2023-11-09 | $53.25M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $52.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $52.77M derived: sum of 2 quarters · filed 2023-11-09 | $52.78M derived: sum of 3 quarters · filed 2023-11-09 | $53.18M 10-K · filed 2023-03-09 |
| 2022-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $174.00K derived: sum of 2 quarters · filed 2023-11-09 | $573.00K 10-Q · filed 2023-11-09 | $609.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $411.00K 10-Q · filed 2023-08-10 | $447.00K derived: sum of 3 quarters · filed 2023-08-10 | $447.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $399.00K 10-Q · filed 2023-05-11 | $435.00K derived: sum of 2 quarters · filed 2023-05-11 | $435.00K derived: sum of 3 quarters · filed 2023-05-11 | $122.87M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $36.00K derived: sum of 2 quarters · filed 2023-03-09 | $122.47M derived: sum of 3 quarters · filed 2023-03-09 | $121.61M 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $122.44M derived: sum of 2 quarters · filed 2022-11-10 | $121.58M 10-Q · filed 2022-11-10 | $121.55M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $122.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $121.58M 10-Q · filed 2022-08-04 | $121.55M derived: sum of 3 quarters · filed 2022-08-04 | $184.73M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$858.00K 10-Q · filed 2022-05-04 | -$885.00K derived: sum of 2 quarters · filed 2022-05-04 | $62.29M derived: sum of 3 quarters · filed 2022-05-04 | |
| 2020-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $63.15M derived: sum of 2 quarters · filed 2022-03-03 | $69.49M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $63.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $69.52M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $6.34M 10-Q · filed 2021-08-10 |